SIGA Stock (NASDAQ:SIGA)
Previous Close
$5.50
52W Range
$5.13 - $12.83
50D Avg
$5.80
200D Avg
$7.11
Market Cap
$372.90M
Avg Vol (3M)
$424.78K
Beta
1.03
Div Yield
$0.60
SIGA Company Profile
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
SIGA Performance
Peer Comparison
| Ticker | Company |
|---|---|
| AVDL | Avadel Pharmaceuticals plc |
| IRWD | Ironwood Pharmaceuticals, Inc. |
| LSDI | Lucy Scientific Discovery Inc. |
| ESPR | Esperion Therapeutics, Inc. |
| NBIX | Neurocrine Biosciences, Inc. |
| SXTC | China SXT Pharmaceuticals, Inc. |
| ORGO | Organogenesis Holdings Inc. |
| PCRX | Pacira BioSciences, Inc. |
| ALKS | Alkermes plc |
| COLL | Collegium Pharmaceutical, Inc. |
| CTLT | Catalent, Inc. |
| ALIM | Alimera Sciences, Inc. |
| RDY | Dr. Reddy's Laboratories Limited |
| PAHC | Phibro Animal Health Corporation |
| DCPH | Deciphera Pharmaceuticals, Inc. |
| ELAN | Elanco Animal Health Incorporated |